Moreover, artificially raising premiums for the youngest plan members to pay for older plan members makes health insurance a more questionable proposition, resulting in younger people dropping their coverage even as the reduction in rates for older people encourages more of them to enroll.
But developing drugs for other addictions is a riskier commercial proposition, largely because so many addicts are poor and, in America at least, their health insurance will not always pay the bill.